[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Stagezero Life Sciences Ltd (GNWSF)

Stagezero Life Sciences Ltd (GNWSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Stagezero Life Sciences Ltd 70 East Beaver Creek Road Unit 30 Richmond Hill A6 L4B 3B2 CAN

www.stagezerolifesciences.com P: 905-209-2030

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

StageZero Life Sciences Ltd is dedicated to the early detection of cancer and multiple disease states through whole blood. The company's test consists of Aristotle(R), a multi-cancer panel for simultaneously screening for cancers from a single sample of blood. StageZero Life Sciences Ltd, formerly known as GeneNews Ltd., is based in TORONTO, ON.

Key Statistics

Overview:

Market Capitalization, $K 22,678
Shares Outstanding, K 62,995
Float, K 62,995
% Float 100.00%
% of Institutional Shareholders 0.02%

Financials:

Annual Sales, $ 4,150 K
Annual Net Income, $ -6,860 K
Last Quarter Sales, $ 2,480 K
Last Quarter Net Income, $ -7,300 K

Growth:

1-Year Return 2.74%
3-Year Return -66.67%
5-Year Return -78.37%
5-Year Revenue Growth 1,157.58%
5-Year Earnings Growth 83.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/13/21
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr -300.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 09/18/20

GNWSF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -165.13%
Profit Margin % -165.30%
Debt/Equity -0.12
Price/Sales 5.65
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage -9.39
60-Month Beta 0.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.